Found: 22
Select item for more details and to access through your institution.
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 343, doi. 10.1007/s00432-019-03118-4
- By:
- Publication type:
- Article
Actionable loss of SLF2 drives B‐cell lymphomagenesis and impairs the DNA damage response.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 9, p. 1, doi. 10.15252/emmm.202216431
- By:
- Publication type:
- Article
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. 16, p. 10433, doi. 10.1093/nar/gku763
- By:
- Publication type:
- Article
SwissTargetPrediction: a web server for target prediction of bioactive small molecules.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. W1, p. W32, doi. 10.1093/nar/gku293
- By:
- Publication type:
- Article
SwissBioisostere: a database of molecular replacements for ligand design.
- Published in:
- Nucleic Acids Research, 2013, v. 41, p. D1137, doi. 10.1093/nar/gks1059
- By:
- Publication type:
- Article
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
- Published in:
- Nature Medicine, 2015, v. 21, n. 10, p. 1163, doi. 10.1038/nm.3952
- By:
- Publication type:
- Article
The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myeloma.
- Published in:
- EMBO Journal, 2022, v. 41, n. 20, p. 1, doi. 10.15252/embj.2022110871
- By:
- Publication type:
- Article
Bioactive Molecules: Perfectly Shaped for Their Target?
- Published in:
- Molecular Informatics, 2011, v. 30, n. 8, p. 677, doi. 10.1002/minf.201100034
- By:
- Publication type:
- Article
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3650, doi. 10.3390/cancers15143650
- By:
- Publication type:
- Article
Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3764, doi. 10.3390/cancers12123764
- By:
- Publication type:
- Article
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 12, p. 3048, doi. 10.1002/1878-0261.12835
- By:
- Publication type:
- Article
Rationale for MYC imaging and targeting in pancreatic cancer.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00843-1
- By:
- Publication type:
- Article
Rationale for MYC imaging and targeting in pancreatic cancer.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00843-1
- By:
- Publication type:
- Article
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer.
- Published in:
- Cellular & Molecular Life Sciences, 2023, v. 80, n. 1, p. 1, doi. 10.1007/s00018-022-04638-y
- By:
- Publication type:
- Article
MTOR inhibitor-based combination therapies for pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Protein pocket and ligand shape comparison and its application in virtual screening.
- Published in:
- Journal of Computer-Aided Molecular Design, 2013, v. 27, n. 6, p. 511, doi. 10.1007/s10822-013-9659-1
- By:
- Publication type:
- Article
PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells.
- Published in:
- Molecular Carcinogenesis, 2009, v. 48, n. 12, p. 1149, doi. 10.1002/mc.20569
- By:
- Publication type:
- Article
Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 10, p. 2248, doi. 10.1002/ijc.27916
- By:
- Publication type:
- Article
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells.
- Published in:
- Archives of Toxicology, 2018, v. 92, n. 7, p. 2227, doi. 10.1007/s00204-018-2229-5
- By:
- Publication type:
- Article
Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip System.
- Published in:
- Biomedicines, 2020, v. 8, n. 12, p. 590, doi. 10.3390/biomedicines8120590
- By:
- Publication type:
- Article
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition.
- Published in:
- Cancer Communications, 2022, v. 42, n. 4, p. 360, doi. 10.1002/cac2.12280
- By:
- Publication type:
- Article
Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseases.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01590-6
- By:
- Publication type:
- Article